Therefore, development of therapeutic strategies that specifically target Pin1 could provide a novel and effective treatment option for patients with TGCTs, particularly those with aggressive, nonseminomatous germ cell tumors. The gene discussed is PIN1; the disease is testicular germ cell tumor.